It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Anxiety-like behavior of rodents is frequently accompanied by reduced exploration. Here, we identify dissociable components of anxiety, fear, and exploratory drive of sated and foraging mice. With the help of behavioral assays, including the open field task, elevated plus maze, dark–light transition task, and beetle mania task, we demonstrate a general increase in exploration by food restriction. Food-restricted mice bred for high anxiety behavior (HAB) showed ameliorated anxiety- but not fear-related behavior. By means of principal component analysis, we identified three independent components, which resemble the behavioral dimensions proposed by Gray’s Reinforcement Sensitivity Theory (approach behavior, avoidance behavior, and decision making). Taken together, we demonstrate anxiolytic consequences of food restriction in a mouse model of anxiety disorders that can be dissociated from a general increase in foraging behavior.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details





1 Research Group Neuronal Plasticity, Max Planck Institute of Psychiatry, Munich, Germany (GRID:grid.419548.5) (ISNI:0000 0000 9497 5095); Max Planck School of Cognition, Leipzig, Germany (GRID:grid.4372.2) (ISNI:0000 0001 2105 1091)
2 Research Group Neuronal Plasticity, Max Planck Institute of Psychiatry, Munich, Germany (GRID:grid.419548.5) (ISNI:0000 0000 9497 5095); Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Department of Psychiatry and Psychotherapy, Freiburg, Germany (GRID:grid.5963.9)
3 Research Group Neuronal Plasticity, Max Planck Institute of Psychiatry, Munich, Germany (GRID:grid.419548.5) (ISNI:0000 0000 9497 5095)
4 Department of Translational Psychiatry, Max Planck Institute of Psychiatry, Munich, Germany (GRID:grid.419548.5) (ISNI:0000 0000 9497 5095)
5 Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Department of Psychiatry and Psychotherapy, Freiburg, Germany (GRID:grid.5963.9)
6 Research Group Neuronal Plasticity, Max Planck Institute of Psychiatry, Munich, Germany (GRID:grid.419548.5) (ISNI:0000 0000 9497 5095); Max Planck School of Cognition, Leipzig, Germany (GRID:grid.4372.2) (ISNI:0000 0001 2105 1091); Central Nervous System Diseases Research (CNSDR), Boehringer Ingelheim Pharma & Co KG, Biberach an der Riss, Germany (GRID:grid.420061.1) (ISNI:0000 0001 2171 7500)